Oryzon Genomics SA
MAD:ORY
Oryzon Genomics SA
MAD:ORY
Price:
3.17
EUR
-0.16%
Market Closed
Market Cap:
€253.3m
Cash Flow Statement
Cash Flow Statement
Oryzon Genomics SA
Oryzon Genomics SA
Currency: EUR
| Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||
| Net Income |
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
1
|
2
|
2
|
2
|
1
|
1
|
|
| Cash Taxes Paid |
(2)
|
(2)
|
(5)
|
(3)
|
0
|
(2)
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
3
|
2
|
4
|
2
|
(1)
|
1
|
|
| Cash from Operating Activities |
(2)
N/A
|
(3)
-45%
|
(1)
+79%
|
(2)
-229%
|
(6)
-201%
|
(3)
+47%
|
|
| Investing Cash Flow | |||||||
| Capital Expenditures |
(14)
|
(16)
|
(15)
|
(11)
|
(8)
|
(8)
|
|
| Other Items |
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
|
| Cash from Investing Activities |
(14)
N/A
|
(16)
-16%
|
(15)
+12%
|
(11)
+22%
|
(8)
+31%
|
(8)
+2%
|
|
| Financing Cash Flow | |||||||
| Net Issuance of Common Stock |
(1)
|
(1)
|
(2)
|
0
|
(0)
|
29
|
|
| Net Issuance of Debt |
10
|
11
|
8
|
11
|
5
|
2
|
|
| Other |
0
|
0
|
0
|
1
|
2
|
1
|
|
| Cash from Financing Activities |
9
N/A
|
10
+16%
|
6
-41%
|
10
+64%
|
7
-31%
|
32
+361%
|
|
| Change in Cash | |||||||
| Effect of Foreign Exchange Rates |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Net Change in Cash |
(7)
N/A
|
(9)
-25%
|
(9)
+2%
|
(3)
+63%
|
(7)
-98%
|
21
N/A
|
|
| Free Cash Flow | |||||||
| Free Cash Flow |
(16)
N/A
|
(19)
-19%
|
(15)
+21%
|
(13)
+12%
|
(13)
-1%
|
(11)
+21%
|
|
Switch to:
Switch to:
See Also
Discover More
